Exscientia Revenue Per Share from 2010 to 2024

EXAIDelisted Stock  USD 4.84  0.00  0.00%   
Check Exscientia financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Exscientia's main balance sheet or income statement drivers, such as , as well as many indicators such as . Exscientia financial statements analysis is a perfect complement when working with Exscientia Valuation or Volatility modules.
  
Check out the analysis of Exscientia Correlation against competitors.

About Exscientia Financial Statements

Investors use fundamental indicators, such as Exscientia's Revenue Per Share, to determine how well the company is positioned to perform in the future. Although Exscientia's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom. Exscientia operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 285 people.

Currently Active Assets on Macroaxis

Check out the analysis of Exscientia Correlation against competitors.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Exscientia Stock

If you are still planning to invest in Exscientia ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Exscientia's history and understand the potential risks before investing.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Stocks Directory
Find actively traded stocks across global markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities